Clinical Trial Update: A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and glucose control effects of sotagliflozin 400 mg and 200 mg in adults with type 2 diabetes and severe kidney impairment (CKD …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 4 | Phase 3 | Status: COMPLETED | Results posted: 2021-06-25